Bio networking dayYou are hereAbout BioAlpsPhoto galleryArchives photo galleryBioAlps networking day (part 1)Bio networking day
Find an actor
4à6 de BioAlps - Tornos15.03.2018Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.
Tolerys SATherapeutics & Diagnostics, Other
Tolerys SA is an early stage biotech company developing a novel anti-inflammatory immunotherapy named EFD BCG. This product is derived from BCG vaccine using a patented inactivation process.
Therapeutics & Diagnostics, Vaccines
Preclinical studies proved that EFD BCG relies on its unique capacity to induce regulatory T cells in several models of chronic inflammatory diseases and is associated with a favorable safety profile.
In parallel to preclinical R&D, Tolerys SA has developed EFD BCG's manufacturing process and is preparing a first-in-man clinical trial.